LERNER LORENA RAQUEL enters KEROS THERAPEUTICS, INC. with 35K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 8/15/2025ACC: 0001415889-25-022079
Officer· Chief Scientific Officer
Since Feb 2026
35K
Baseline shares
100% direct
35K
Direct ownership
1 position
41.38K
Derivative underlying
3 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned35K
Total
35K direct35K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 35K | Direct |
| Total | 35K | 35K direct |
Derivative Holdings3
Employee Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
10.88K
Shares owned
N/A
Exercise price
43.99
Expiration
—
Exercise window
—
Employee Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
7.50K
Shares owned
N/A
Exercise price
54.38
Expiration
—
Exercise window
—
Employee Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
23K
Shares owned
N/A
Exercise price
56.18
Expiration
—
Exercise window
—
Total
Underlying
41.38K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock | 43.99 | — | — | 10.88K | N/A |
| Employee Stock Option (Right to Buy) Direct | Common Stock | 54.38 | — | — | 7.50K | N/A |
| Employee Stock Option (Right to Buy) Direct | Common Stock | 56.18 | — | — | 23K | N/A |
| Total | 41.38K | 0.00 | ||||